DGAP-News: Nanostart-holding MagForce AG Announces Capital Increase from Authorized Capital
(firmenpresse) - DGAP-News: Nanostart AG / Key word(s): Miscellaneous
Nanostart-holding MagForce AG Announces Capital Increase from
Authorized Capital
01.02.2012 / 09:31
---------------------------------------------------------------------
Nanostart-holding MagForce AG Announces Capital Increase from Authorized
Capital
- Proceeds from the capital increase will be used for the
commercialization of the NanoTherm(R) technology and further clinical
development along with the expansion of commercial and strategic
partnerships
Frankfurt / Berlin - February 1, 2012 - The Management Board of
Nanostart-holding MagForce AG, a leading medical technology company
focusing on nanomedicine in oncology, and its Supervisory Board yesterday
approved an increase in the company's share capital from EUR 4,127,041.00
up to EUR 4,952,449.00 through the partial utilization of its existing
authorized capital of up to EUR 825,408.00 newly registered common shares
with no par value common with a nominal value of EUR 1.00 per share against
cash contributions.
The company will offer its shareholders the right to subscribe new shares
at a ratio of 5:1 (indirect subscription right). For five 'old' shares, one
'new' share can be purchased. The subscription period begins for
shareholders on Friday, February 3, 2012 and will run for two weeks through
February 16, 2012. The subscription price is EUR 5.50. The rights offering
for shareholders is expected to be published on Thursday, February 2, 2012
in the electronic Federal Gazette.
If all shares are not subscribed, shareholders have the possibility to
purchase additional shares to their subscription rights. Unsubscribed
shares will first be offered to current shareholders, and any remaining
shares will be offered in a private placement to institutional investors.
The proceeds from the capital increase will be used for further
commercialization and the clinical development of the NanoTherm(R)
technology along with the expansion of commercial and strategic
partnerships.
The transaction is being managed by Silvia Quandt&Cie. AG. Silvia Quandt&Cie. AG operates in Germany as a tied agent pursuant to section 2
paragraph 10 of the German Banking Act (KWG) in the name and on behalf of
biw Bank für Investments und Wertpapiere AG with regard to services
pursuant to section 1 paragraph 1a sentence 2 no. 1, 1c and 2 KWG.
About Nanostart:
Nanostart AG (OTCQX: NASRY) headquartered in the German financial capital
of Frankfurt, is a leading nanotechnology investment company, with
portfolio companies spanning the globe from Silicon Valley to Singapore.
The company provides venture capital financing for nanotechnology companies
in various growth phases with a focus on innovation-driven industries of
the future such as cleantech, life sciences and IT/electronics. Through its
subsidiary Nanostart Asia and the venture capital fund in Singapore,
Nanostart is proud to be the investment partner of the Singaporean
government.
About MagForce:
MagForce AG (XETRA: MF6) is a leading medical technology company focusing
on nanomedicine in oncology. The company's proprietary procedure,
NanoTherm(R) therapy, enables the targeted treatment of solid tumors
through the intratumoral generation of heat via activation of magnetic
nanoparticles. NanoTherm(R), NanoPlan(R), and NanoActivator(TM) are
components of the therapy and have received EU-wide regulatory approval as
medical devices for the treatment of brain tumors. MagForce, NanoTherm,
NanoPlan and NanoActivator are trademarks of MagForce AG in selected
countries. For more information, please visit www.magforce.com.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of
offers to purchase or subscribe to securities. There will be no public
offering of securities of Nanostart AG in conjunction with the existing
listing of its shares in the 'Entry Standard' segment of the regulated
unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This
notice does not constitute a securities prospectus. Neither this notice nor
the information contained within is intended for direct or indirect
distribution within Canada, Australia or Japan.
Media contact:
Nanostart AG
Dr. Hans Joachim Duerr
Head of Corporate Communications
Goethestrasse 26-28
D-60313 Frankfurt, Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 150
e-mail: presse(at)nanostart.de
End of Corporate News
---------------------------------------------------------------------
01.02.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
154843 01.02.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 01.02.2012 - 09:31 Uhr
Sprache: Deutsch
News-ID 109749
Anzahl Zeichen: 5937
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 329 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Nanostart-holding MagForce AG Announces Capital Increase from Authorized Capital"
steht unter der journalistisch-redaktionellen Verantwortung von
Nanostart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
